Urology · Glen Cove, NY
NPI
1316908692
Since 2006
Specialty
Urology
Code 208800000X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
10 Medical Plz, Suite 101
Glen Cove, NY, 11542
Phone (516) 676-2270
Groups this clinician bills Medicare through
Medicare paid, 2024
$250K
8,993 services
Medicare patients, 2024
654
Average age 76
Drug cost, 2024
$2.0M
3,261 prescriptions
Company payments, 2025
$1,341
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mykola Alyskewycz was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 963 times for 504 patients. In total Mykola Alyskewycz billed 8,993 services in 77 codes, and Medicare paid $250K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 963 | 504 | $15.03 | $14K |
| 81000 Clinical Chemistry | Office | 793 | 436 | $3.94 | $3,124 |
| 99214 Office E&M - Established | Office | 724 | 382 | $115.89 | $84K |
| 51798 Ultrasound - Nonspecific | Office | 498 | 307 | $10.98 | $5,470 |
| 99213 Office E&M - Established | Office | 302 | 207 | $80.52 | $24K |
| 87086 Bacterial Culture | Office | 206 | 141 | $7.91 | $1,629 |
| 36415 Venipuncture Blood Collection | Office | 123 | 109 | $8.46 | $1,040 |
| 81003 Clinical Chemistry | Office | 101 | 94 | $2.20 | $222 |
| 87186 General Laboratory | Office | 91 | 39 | $8.48 | $771 |
| 84153 Clinical Chemistry | Office | 76 | 68 | $18.02 | $1,370 |
| 99204 Office E&M - New | Office | 65 | 65 | $157.96 | $10K |
| 52000 Cystourethroscopy | Office | 61 | 49 | $234.20 | $14K |
| 87088 Bacterial Culture | Office | 52 | 40 | $7.93 | $412 |
| 87077 Bacterial Culture | Office | 51 | 39 | $7.92 | $404 |
| 99203 Office E&M - New | Office | 40 | 40 | $100.48 | $4,019 |
By year: 2022 $222K for 9,866 services; 2023 $243K for 12,220 services; 2024 $250K for 8,993 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 793 | 436 | $3.94 | $3,124 |
| 87086 Bacterial Culture | 206 | 141 | $7.91 | $1,629 |
| 36415 Venipuncture Blood Collection | 123 | 109 | $8.46 | $1,040 |
| 81003 Clinical Chemistry | 101 | 94 | $2.20 | $222 |
| 87186 General Laboratory | 91 | 39 | $8.48 | $771 |
| 84153 Clinical Chemistry | 76 | 68 | $18.02 | $1,370 |
| 87088 Bacterial Culture | 52 | 40 | $7.93 | $412 |
| 87077 Bacterial Culture | 51 | 39 | $7.92 | $404 |
Medicare prescription drug claims, 2024
In 2024, the drug Mykola Alyskewycz prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,284 prescriptions and refills. In total Mykola Alyskewycz wrote 3,261 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,284 | 3,087 | 392 | $20K |
| Finasteride Generic | 522 | 1,396 | 156 | $5,930 |
| Myrbetriq Mirabegron | 185 | 255 | 44 | $113K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 129 | 177 | 19 | $3,168 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 94 | 94 | 67 | $659 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 70 | 70 | 43 | $391 |
| Orgovyx Relugolix | 67 | 67 | 12 | $176K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 60 | 60 | 36 | $653 |
| Gemtesa Vibegron | 57 | 75 | Under 11 | $32K |
| Prednisone Generic | 43 | 43 | Under 11 | $151 |
| Xtandi Enzalutamide | 42 | 42 | Under 11 | $602K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 41 | 93 | 15 | $594 |
| Lupron Depot Leuprolide Acetate | 37 | 119 | 14 | $229K |
| Abiraterone Acetate Generic | 36 | 36 | Under 11 | $74K |
| Methenamine Hippurate Generic | 35 | 61 | 12 | $2,903 |
Brand drugs: 482 claims; generic drugs: 2,779 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mykola Alyskewycz $1,341 ($1,341 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $337.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 6 | $337 |
| Sumitomo Pharma America, Inc. 4506.T | 10 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $144 |
| Astellas Pharma US Inc 4503.T | 4 | $130 |
| Endo USA, Inc. | 4 | $94.22 |
| Antares Pharma, Inc. | 4 | $74.72 |
| Verity Pharmaceuticals Inc. | 2 | $68.43 |
| Tolmar, Inc. | 2 | $60.73 |
| Ferring Pharmaceuticals Inc. | 2 | $49.11 |
| Olympus America Inc. | 2 | $46.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.